wall street a late round of computer-driven sell programmes pushed us equity prices sharply lower on a day in which the market had largely held its own in spite of an erosion in ibm''s share price writes karen zagor in new york the dow jones industrial average closed 22.42 lower at 3,310.84 after gaining more than 18 points in the afternoon the more broadly based standard poor's 500 fell 1.17 to 437.98 while the amex composite was down 0.35 at 393.83 the nasdaq composite however climbed 2.76 to 669.01 trading volume on the new york se was more than 215 m shares and rises outnumbered declines by 988 to 825 on monday the dow had closed 7.02 higher at 3,33.26 on thin volume wall street's morning buoyancy was the result of several factors including better-than-expected existing home sales for november a strong consumer confidence index and end-of-year window dressing by money managers the consumer confidence index for december rose to 78.3 from 65.6 in november while the national association of realtors said existing home sales rose 5.8 per cent in november in addition the last week of the year is traditionally a strong period for the stock market ibm fell dollars 2 to dollars 49 3 4 in active trading after merrill lynch cut its long-term investment rating on the stock to above average from buy the dow also came under pressure from heavy selling in minnesota mining manufacturing attributed to profit taking the issue closed dollars 2 3 4 lower at dollars 100 1 8 among other active blue chips at t added dollars 3 8 to dollars 52 1 4 a 52-week high philip morris lost dollars 3 8 to dollars 77 7 8 and disney fell dollars 1 8 to dollars 44 1 8 shares in tiffany the up-market us jeweller soared dollars 3 5 8 to dollars 33 1 8 on news that several analysts had upgraded investment ratings on monday tiffany reported an 8 per cent rise in sales for the eight week holiday period shares in cordis a company which makes specialised medical devices climbed dollars 5 8 to a 52-week high of dollars 36 3 8 the food drug administration approved us marketing of the company's sleuth xt and ptca dilation catheters news that the fda had approved the marketing of taxol a promising new cancer drug derived from the pacific yew tree helped shares in bristol-myers advance dollars 3 4 to dollars 68 1 2 bristol-myers has received permission to market taxol to women with ovarian cancer who have failed to respond to chemotherapy canada toronto ended little changed in active trading boosted by a large block trade in international verifact inc shares based on preliminary data the 300 composite index was down 5.04 points or 0.15 per cent to 3,314.87 with advances leading declines 316 to 223 volume rose to 40.83 m shares compared with 16,01 m at thursday's half-day session canadian markets were closed friday and monday for the christmas and boxing day holidays